Zyrova F 5 Tablet
By Zyrova F
Rx
10 Tablet in a Strip

Composition
Fenofibrate(145mg) + Rosuvastatin(5mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
March, 2027
About Zyrova F 5 Tablet
Zyrova F 5 Tablet is a medication that combines two lipid-lowering drugs aimed at reducing cholesterol and triglyceride levels in the blood to lower the risk of heart disease. The tablet can be taken with or without food but should be taken at the same time each day to establish a routine. Your doctor will determine the appropriate dosage based on your lipid levels and response to the treatment. While individuals with high cholesterol and triglyceride levels may not feel unwell, discontinuing the medication can lead to increased lipid levels, worsening the condition, and escalating the risk of heart disease and stroke.
Regular monitoring of cholesterol and triglyceride levels is essential while taking Zyrova F 5 Tablet. This medication should be part of a comprehensive treatment plan that includes a healthy low-fat diet, regular exercise, cessation of smoking, moderate alcohol consumption, and weight management. Although you can eat normally while on this medication, it is advisable to avoid high-fat foods. Common side effects may include nausea, stomach pain, constipation, headache, flatulence, and muscle pain, which are usually mild and transient. However, you should consult your doctor if these side effects persist or if you experience any concerning symptoms like yellowing of the eyes or unexplained muscle pains.
Zyrova F-5 Tablet 10's functions by lowering total cholesterol and triglyceride levels to prevent cardiovascular events such as heart attack and stroke. The tablet consists of Rosuvastatin and Fenofibrate, with Rosuvastatin reducing cholesterol and triglycerides while increasing good cholesterol levels and improving their removal from the blood. Fenofibrate works to lower triglyceride levels. It is crucial to follow the prescribed dosage frequency and inform your doctor of any persistent side effects.
ZYROVA F10 TABLET, another variant of the medication, is a combination of Rosuvastatin and Fenofibrate used to treat hyperlipidemia. This condition involves elevated levels of bad cholesterol and triglycerides in the blood that, if untreated, can lead to blockages in blood vessels, increasing the risk of heart-related complications. Alongside ZYROVA F10 TABLET treatment, adherence to a recommended diet and lifestyle changes are essential for optimal results. Patients with liver or kidney issues should consult their doctor before starting this medication, and regular monitoring of various health parameters is necessary during the treatment.
In summary, Zyrova F 5 Tablet, Zyrova F-5 Tablet 10's, and ZYROVA F10 TABLET are lipid-lowering drugs effective in reducing cholesterol and triglyceride levels to mitigate the risk of heart diseases and related complications. It is vital to follow the prescribed guidelines, maintain a healthy lifestyle, and promptly report any unusual symptoms to ensure the safe and effective use of these medications.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹202.9
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024